Selbyville, Delaware, Jan. 09, 2024 (GLOBE NEWSWIRE) --
The lipid market valuation is estimated to surpass USD 23.8 billion by 2032, as reported in a research study by Global Market Insights Inc.
The heightened demand for lipid-lowering solutions, driven by increasing health consciousness, will accelerate market growth over 2024–2032. In addition, the establishment of advanced lipid production facilities will further fuel this growth. As consumers prioritize cardiovascular health, the market responds with innovative products, pharmaceutical interventions, and functional foods. This confluence of factors will significantly drive the market size , meeting the evolving needs of individuals seeking effective lipid-related solutions.
For instance, in 2023, Evonik inaugurated a GMP facility in Hanau, Germany, specializing in manufacturing lipids for advanced pharmaceutical drug delivery. This facility caters to customers requiring lipid quantities for clinical and small-scale commercial production. The new site enhances Evonik's capabilities, aligning with its existing lab and commercial production to support partners at various development and commercialization stages effectively. This launch contributes to the strengthening of the lipid industry by ensuring a robust supply chain for advanced pharmaceutical drug delivery applications.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/6255
The lipid market from the sterols segment is projected to capture a substantial share by 2032, due to increasing awareness of their cholesterol-lowering benefits and growing health-conscious consumer preferences. Sterols, known for their efficacy in managing cholesterol levels, are witnessing rising demand. The incorporation of sterols in various food and dietary supplements will further fuel this trend, positioning the sterols segment as a key player in the expanding market size, catering to the evolving needs of health-conscious individuals.
The pharmaceuticals segment could contribute decently to the lipid market size between 2024 and 2032, attributed to the escalating demand for lipid-lowering medications to address cardiovascular conditions. As lifestyle-related diseases become more prevalent, the pharmaceutical segment is strategically positioned to offer innovative solutions. Continuous research and development efforts, in line with advancements in lipid-related pharmaceuticals, further solidify the pharmaceuticals segment's prominence in catering to the increasing global demand for lipid-related healthcare solutions.
The APAC lipid market will register remarkable expansion from 2024 to 2032, propelled by factors such as increasing healthcare awareness, rising prevalence of lifestyle-related diseases, and a growing aging population. This surge in demand for lipid-related products aligns with the region's economic growth and evolving healthcare landscape. Key players are strategically focusing on expanding their presence in the Asia Pacific, recognizing the significant market potential and the region's increasing influence in the market outlook.
Major players involved in lipid market include Archer Daniels Midland Company (ADMC), Bunge Limited, Cargill, Willmar International Limited, Louis Dreyfus Company, IOI Corporation Berhad, Stepan Company, AAK AB, Croda International Plc, BASF SE, Bioriginal Food & Science Corporation, Dupont De Nemours, Inc., Kerry Group, Corbion N.V., and Loders Croklaan.
These industry players are strategically enhancing their presence in the lipid industry by employing a multifaceted approach; they focus on research and development, introduce innovative products, and establish strategic collaborations. This proactive strategy boosts their market share and will position them as key players in meeting the growing demand for lipid-related solutions as the market continues to evolve with advancements in healthcare and consumer preferences.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/6255
For instance, in 2022, Sun Pharma introduced a novel oral lipid-lowering medication in India under the brand name Brillo. This drug is designed to lower low-density lipoprotein (LDL) cholesterol levels effectively. This launch aligns with the company's plan to broaden its presence and supply chain operations in the rapidly expanding APAC market.
Partial chapters of report table of contents (TOC):
Chapter 2 Executive Summary
2.1 Lipid Market 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Source trends
2.4 Type trends
2.5 Application trends
2.6 Regional trends
Chapter 3 Lipid Market Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing awareness regarding health
3.2.1.2 Increasing use of supplements
3.2.1.3 Increasing population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Price volatility of raw materials
3.2.2.2 Regulatory and Compliance Issues
3.2.2.3 Sustainability and Environmental Concerns
3.3 Growth potential analysis
3.3.1 By source
3.3.2 By application
3.3.3 By type
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 APAC
3.6 Pricing analysis, 2022
3.7 Technology landscape
3.7.1 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
Browse our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
Browse Related Reports:
Nutritional Lipids Market Size By Product (Omega-3 {Alpha-Linolenic Acid, Docosahexaenoic Acid, EPA}, Omega-6, MCTs), By Application (Dietary Supplements, Infant formula, Pharmaceuticals, Food Fortification, Animal Nutrition), Form, Source, 2023 – 2032
https://www.gminsights.com/industry-analysis/nutritional-lipids-market
Maltodextrin Market Size - By Source (Corn-Based, Wheat-Based, Potato-Based, Cassava-Based), Application (Food & Beverages, Pharmaceuticals, Cosmetics & Personal Care, Industrial Applications), Grade, Growth Prospects, Regional Outlook & Forecast, 2024 – 2032
https://www.gminsights.com/industry-analysis/maltodextrin-market
About Global Market Insights Inc.
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
